Clinical Trial Update: DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY [Phase 2]

View source ↗

Summary

Phase 2 clinical trial DAANCE for chemotherapy-induced peripheral neuropathy in breast cancer patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• DAANCE

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Cancer of the Breast, Chemotherapy-induced Neuropathy | Phase 2 | Status: RECRUITING